Business Wire

WA-SPIE

12.1.2021 18:11:31 CET | Business Wire | Press release

Share
SPIE, The International Society for Optics and Photonics, Announces Its 2021 Society Awards

The Awards Committee of SPIE, the international society for optics and photonics , today announced the recipients of its prestigious annual awards . Honoring transformative advancements in multiple areas — including medicine, astronomy, lithography, optical metrology, and community-focused achievements — the Society's awards recognize technical accomplishments as well as committed service to SPIE and support of its organizational mission.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210112005279/en/

SPIE Gold Medal: Hugo Thienpont
In recognition of his profound and durable impact on society and pioneering vision for photonics. The different disruptive instruments that Thienpont has developed and implemented during the past decades have generated a tangible impact on education, research, innovation, and societal well-being in Flanders, across Europe, and beyond.

SPIE President's Award: Maria Yzuel
In recognition of her inspirational leadership in the field of optics; tireless dedication to the promotion of equity, diversity, and inclusion in science; and many years of outstanding service to SPIE and its international community.

SPIE Directors' Award: Maryellen Giger
In recognition of her outstanding service to SPIE and the optics and photonics communities. Giger has been a key voice in data-driven approaches, and an active leader in pushing forward our equity, diversity, and inclusion efforts.

SPIE Mozi Award: Xiang Zhang
In recognition of his seminal, fundamental contributions in optical physics and experimental research in the optical perfect lens.

SPIE Britton Chance Award in Biomedical Optics: Enrico Gratton
In recognition of a lifetime of contributions to the field of biomedical optics, including pioneering theoretical and instrumentation developments in fluorescence spectroscopy, fluorescence microscopy, and diffuse medical imaging.

SPIE Biophotonics Technology Innovator Award: Keisuke Goda
In recognition of his significant contributions to the field of biophotonics through the development of innovative ultrafast optical imaging and spectroscopy methods and their integration into microfluidic platforms.

SPIE A.E. Conrady Award in Optical Engineering: Dave Aikens
In recognition of his world-leading expertise, training programs, and development of optical engineering and optical standards.

SPIE Harrison H. Barrett Award in Medical Imaging: Kevin Berbaum
In recognition of more than three decades of dedication in the study of Satisfaction of Search, and significant contributions to receiver operating characteristic analysis.

SPIE Harold E. Edgerton Award in High-Speed Optics: Vladislav Yakovlev
In recognition of his remarkable contributions to ultrafast laser technology, ultrafast spectroscopies, and ultrafast imaging and their applications, as well as for his SPIE outreach.

SPIE Dennis Gabor Award in Diffractive Optics: Małgorzata Kujawińska
In recognition of her outstanding and manifold contributions to holographic technologies in optical metrology, optical imaging, and optical information processing, as well as for her extraordinary dedication to the SPIE community and widely recognized international leadership in applied optical engineering.

SPIE George W. Goddard Award in Space and Airborne Optics: Thomas Rimmele
In recognition of his invention and application of extended-source adaptive optics delivering diffraction-limited, high-resolution imaging of the solar surface.

SPIE G. G. Stokes Award in Optical Polarization: Nirmalya Ghosh
In recognition of his extensive research in the field of Mueller matrix polarimetry and applications of Mueller matrix polarimetric spectroscopy and imaging in various interdisciplinary fields including quantum optics, space optics, biomedical optics, chemistry, material science, and fluorescence spectroscopy.

SPIE Chandra S. Vikram Award in Optical Metrology: Krzysztof Patorski
In recognition of his seminal contributions to diffraction, interferometry, moiré fields, and fringe analysis with applications in optical metrology, experimental mechanics, and biomedical engineering.

SPIE Frits Zernike Award in Microlithography: Bruce Smith
In recognition of his many contributions as a researcher and leader in the microlithography community, and for his achievements in educating an entire generation of engineers who continue to advance academic research and industry understanding.

SPIE Diversity Outreach Award: Celine d'Orgeville
In recognition of her leadership in diversity, inclusion, and equity activities in Australia and elsewhere in the world.

SPIE Maria Goeppert-Mayer Award in Photonics: Jorge Ojeda-Castañeda
In recognition of his outstanding contributions to modern and advanced imaging technologies for the development of phase-space representations of imaging devices, which enable the design of innovative techniques for extending field depth, and for proposing novel designs employing lenses with tunable optical power.

SPIE Maiman Laser Award: Anne Tropper
In recognition of her pioneering contributions to rare-earth doped fiber and optically pumped semiconductor lasers.

SPIE Early Career Achievement Award — Academic Focus: Muyinatu Bell
In recognition of her pioneering contributions to photoacoustic imaging for surgical guidance, including innovative technology designs, novel deep learning applications, informative spatial coherence beamforming theory, and visionary clinical possibilities.

SPIE Early Career Achievement Award — Industry/Government Focus: Sergio Carbajo
In recognition of his capacity to unify ultrafast and quantum optics with X-ray science to advance the mission of Basic Energy Sciences facilities.

SPIE Maria J. Yzuel Educator Award: Bishnu Pal
In recognition of four decades of sustained contributions in education, outreach, research, technical program committees of global flagship conferences, and editing of four popular publications in guided wave optics and photonics.

SPIE Aden and Marjorie Meinel Technology Achievement Award: Shouleh Nikzad
In recognition of her pioneering and sustained contributions to the development of ultraviolet instrument technologies, especially imagers for space exploration and extension of their use in terrestrial applications.

The complete listing of all SPIE awards and recipients is available here .

About SPIE

SPIE is the international society for optics and photonics, an educational not-for-profit organization founded in 1955 to advance light-based science, engineering, and technology. The Society serves more than 258,000 constituents from 184 countries, offering conferences and their published proceedings, continuing education, books, journals, and the SPIE Digital Library. In 2020, SPIE provided over $5.8 million in community support including scholarships and awards, outreach and advocacy programs, travel grants, public policy, and educational resources. www.spie.org .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye